| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Galectin Therapeutics Inc (NASDAQ: GALT)
GALT Technical Analysis
4
| As on 9th Jun 2023 GALT SHARE Price closed @ 1.52 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.72 & Strong Sell for SHORT-TERM with Stoploss of 2.04 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GALTSHARE Price
| Open | 1.56 | Change | Price | % |
| High | 1.56 | 1 Day | -0.02 | -1.30 |
| Low | 1.51 | 1 Week | -0.05 | -3.18 |
| Close | 1.52 | 1 Month | -0.22 | -12.64 |
| Volume | 20900 | 1 Year | -0.78 | -33.91 |
| 52 Week High 2.48 | 52 Week Low 1.03 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| GALT Daily Charts |
GALT Intraday Charts |
Whats New @ Bazaartrend |
GALT Free Analysis |
|
|
GALT Important Levels Intraday
| RESISTANCE | 1.62 |
| RESISTANCE | 1.59 |
| RESISTANCE | 1.57 |
| RESISTANCE | 1.55 |
| SUPPORT | 1.49 |
| SUPPORT | 1.47 |
| SUPPORT | 1.45 |
| SUPPORT | 1.42 |
GALT Forecast April 2024
| 4th UP Forecast | 2.46 |
| 3rd UP Forecast | 2.16 |
| 2nd UP Forecast | 1.97 |
| 1st UP Forecast | 1.79 |
| 1st DOWN Forecast | 1.25 |
| 2nd DOWN Forecast | 1.07 |
| 3rd DOWN Forecast | 0.88 |
| 4th DOWN Forecast | 0.58 |
GALT Weekly Forecast
| 4th UP Forecast | 2.39 |
| 3rd UP Forecast | 2.11 |
| 2nd UP Forecast | 1.94 |
| 1st UP Forecast | 1.77 |
| 1st DOWN Forecast | 1.27 |
| 2nd DOWN Forecast | 1.10 |
| 3rd DOWN Forecast | 0.93 |
| 4th DOWN Forecast | 0.65 |
GALT Forecast2024
| 4th UP Forecast | 4.51 |
| 3rd UP Forecast | 3.55 |
| 2nd UP Forecast | 2.96 |
| 1st UP Forecast | 2.36 |
| 1st DOWN Forecast | 0.68 |
| 2nd DOWN Forecast | 0.08 |
| 3rd DOWN Forecast | -0.51 |
| 4th DOWN Forecast | -1.47 |
Galectin Therapeutics Inc ( NASDAQ USA Symbol : GALT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GALT Business Profile
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is (GR-MD-02) belapectin galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia. Address: 4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service